Case Study: External Genital Warts Phase III

A leading pharmaceutical company with a focus on men and women’s health selected Novella Clinical’s Dermatology Division to provide patient recruitment services for a Phase III external genital warts study. The sponsor selected Novella because of its reputation as a provider of patient recruitment strategies that drive enrollment and accelerate timelines. With its proven patient recruitment process and a record of successfully enrolled clinical studies, Novella was poised to save the sponsor time and budget. Unique predictive enrollment model reduced projected enrollment period from 52 to 30 weeks.